1. Abdullaer FI, Espinosa-Aguirrej J (2004) Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials , concer –Detect Prev 28:429–432
2. Anderson D, Bishop JB, Garner RC, Ostrosky-Wegman P, Selby PB (1995) Cyclophosphamide: review of its mutagenicity for an assessment of potential germ cell risks. Mutat Res 330(1-2):115–81
3. Bisset NG, Wichtl M (2001) Herbal Drugs and phytopharmaceuticals, a hand book for practice on a scientific basis, (2ed). med pharm. scientific publisher. CRC press, London, pp. 167–169
4. Bokser L, Szende B, Schally AV (1990) Protective effects of D- TypG – luteinizing hormone-releasing hormone micro capsules against cyclophosphamid –induced gonadotoxicity in Female rats. Brit j cancer 61–895
5. Das UB, Mallick M, Debnath JM, Ghosh D (2002) Protective effect of ascorbic acid on cyclophosphamide induced testicular gametogenic and androgenic disorders in male rats. Asian J Androl 4(3):201–207